RNA splicing, and variations in this process referred to as alternative splicing, are critical aspects of gene regulation in eukaryotes. From environmental responses in plants to being a primary link between genetic variation and disease in humans, splicing differences confer extensive phenotypic changes across diverse organisms 1-3 . Current approaches for analysing splicing rely on quantifying variant transcripts (i.e., isoforms) or splicing events (i.e., intron retention, exon skipping etc) 4,5 . However, regulation of splicing occurs at the level of selection of individual splice sites, which results in variation in the abundance of isoforms and/or splicing events. Here, we present a simple approach to quantify the strength of individual splice sites, which determines their selection in a splicing reaction.
Introduction
During mRNA formation, certain sections of the transcribed RNA (introns) are removed with joining of the adjacent regions (exons) in a process known as splicing. Splicing is a fundamental process in eukaryotic gene regulation [6] [7] [8] . Introns removed during the splicing process typically harbour canonical sequences at the 5' beginning (GT) and the 3' end (AG), which facilitate their identification as splice sites [9] [10] [11] . However, non-canonical splice sites and alternative GT or AG sites could also be used for splicing 12 . Selection of splice sites is a critical determinant of the products of splicing. Differential selection of splice sites gives rise to Alternative Splicing (AS), conferring both proteome diversity and phenotypic plasticity 6, 13 . Changes in splicing can modulate phenotypes across diverse organisms including sex-determination in flies, stress response in plants and genetic diseases in humans 1, 3, 6, [13] [14] [15] .
Current approaches to analyse splicing involve exploration of the transcriptome with nextgeneration sequencing, still mostly with short-read RNA-seq data 4, 5, 16, 17 . These approaches rely on mapping the short-read sequences to the gene and subsequently take two distinct strategies. The first strategy relies on quantifying splice variants (isoforms) based on the distribution of the reads observed in the RNA-seq data (Fig. 1a ). Accurate estimation of isoform abundance requires a comprehensive understanding of the potential transcript isoforms, which is often lacking. In fact, there are efforts to obtain comprehensive reference transcriptome, which could help in such analysis 18 . In addition, short reads give evidence only for a small fragment of a transcript, and many regions do not differ between isoforms. Therefore, it is impossible to accurately assign every read to its parent isoform 16, 19 . As a result of this, reads that may come from a novel isoform, could be wrongly attributed to a known isoform, which can lead to misleading biological interpretation 20, 21 .
An alternative approach evolved from a historical description of various types of splicing events such as intron retention, exon skipping, mutually exclusive exons and 5' and 3' alternative splice sites etc 22, 23 . Several approaches including rMATS 24 , ASD 25 , SUPPA2 26 rely on quantifying splicing events. However, grouping splicing events across different genes to make inferences (e.g., increase in exon skipping or intron retention in a mutant compared to wild type) suggests biological categorization and common regulatory mechanism, which can be misleading. More recently, complexity-aware approaches such as MAJIQ 27 , Leafcutter 28 and Whippet 4 have taken alternative approaches, which somewhat minimise these impacts.
As described originally 22, 23 , the strength of the splice site defines patterns of splicing that governs the type of mRNAs produced. We reason that regulatory decisions on splicing occur at the level of individual splice sites rather than at the level of splicing events/isoforms. The extent of utilization or non-utilization of splice sites decides the type of transcripts produced. Splice-site selection affects individual (donor or acceptor) rather than pairs of splice sites (donor/acceptor), which leads to variation in splicing. For example, the same 5' donor GT site can have alternative acceptor AG sites, which uncouples pairs of splice sites in their use. Therefore, there is a need to assess splicing at the level of individual splice sites if one has to understand the regulation of the specificity of splicing. Nevertheless, to date, there has not been much attempt to estimate the degree of utilization of any given splice site.
Here we present a conceptually different approach to analyse splicing and provide its bioinformatic implementation. We describe SpliSER (Splice-site Strength Estimate from RNAseq), a bioinformatic tool to carry out denovo identification of individual splice sites from the RNA-seq data and derive a quantitative measure of their utilization. This approach moves away from analysing splicing at the level of isoforms or events. Splice-site Strength Estimates (SSE) increase the power to analyse regulation of splicing variation across the genome at a fine-scale resolution. We show an implementation of SpliSER to carry out GWAS analysis that allows us to detect SpliSE-QTLs, using the SSE as a quantitative phenotype. As a proof-of principle, using a pilot-dataset with 1500 sites that represent genes known to undergo alternative splicing and nonsense mediated mRNA decay 29, 30 , we map and show that with cis-regulatory variation and competition between splice-sites are among key determinants of differential splicing in these genes among natural accessions of Arabidopsis thaliana. Our strategy provides a powerful approach to decipher regulators of splicing and is widely applicable across diverse organisms.
Results
We developed the idea of quantifying the usage of a given splice site earlier 21 , which we now refer to as Splice-site Strength Estimate (SSE). For any splice site (i.e., splice donor site), there are 4 types of reads that provide information about its usage ( Fig. 1 a & 1b) . First there are split reads that map perfectly with a gap between splice site and its partner sites. We call these reads as a-reads that provide evidence for the use of that splice site ( Fig. 1b ), independent of its partners (i.e., acceptor sites). Second, there are reads that cover the exon-intron junction (b1 reads), which provide evidence of non-usage of the target site ( Fig.1b ). We then use the historical concept of "competing splice sites" 31, 32 to define additional reads that provide evidence of non-usage. If two donor sites partner with the same acceptor site, obviously both events cannot occur in the same transcript and thus the evidence for effective usage for one site becomes the evidence for the inefficient usage of the other site. These reads fall in two categories. Reads that define competitive splicing while also giving evidence for non-usage of the target site (b2-SIMPLE) or reads that define competitive splicing without read coverage of the target site (b2-CRYPTIC). While considering the total number of b2 reads, we apply weightings on the b2-CRYPTIC reads. Thus, SSE is derived as the ratio of the evidence of utilization over the evidence of total possible utilization ( Fig. 1c ).
We further developed this concept into a bioinformatics pipeline, which we call as SpliSER ( Fig. 1d ). SpliSER uses the list of junctions to identify the splice sites from the RNA-Seq data. SpliSER, per se, is annotation-independent, yet allows the use of annotation when available. SpliSER has three different steps in its calculation of SSE. First, it uses a splice junction file to identify splice sites and records the counts of a reads for each of splice sites detected. Second, it provides the counts of b1 reads. Third, it analyses all the possible partners, quantifies them and provides a count of different b2 reads. Finally, it uses all of these metrics, applies filters (see detailed methods) and produces the SSE for all splice sites detected in the RNA-seq data.
To assess the accuracy of the SSE, we exploited natural variation in Arabidopsis thaliana. We reasoned that if our estimates are accurate, for accessions with mutations in splice sites, the SSE would be close to 0 for that site and will differ from other sites in the same gene.
We identified accessions with splice-site mutations at FLOWERING LOCUS M (FLM), which is known to undergo alternative splicing 33 from the 1001 genome data. After confirming the mutations by Sanger sequencing, we downloaded the RNA-seq data for these accessions from the 1001 genome project 34 and ran SpliSER across the FLM locus. Consistent with our predictions, we found the SSE of only mutated sites to be close to 0 unlike other sites known to be spliced with full efficiency (e.g., GT5, GT6, AG5, AG6, 21 ). In addition, the effect at a particular site was exclusive to accessions with mutations, confirming the specificity of our estimates ( Fig. 2a ). RT-PCR experiments confirmed alternative splicing, consistent with our estimates (Fig. 2b ). Although total FLM expression level is substantially reduced in some of these accessions ( Fig. 2b ), we were able to estimate accurately, which indicates that we could pick up splicing differences independent of variation in gene expression.
SSE is a quantitative measure that can be used as a phenotype in GWAS to identify potential regulatory variation. To explore this possibility, we downloaded 6584 RNA-Seq datasets representing 728 accessions from the 1001 genome project 34 . Since we sought to compare the SSEs across accessions, we mapped all of these sequences against the TAIR10 Arabidopsis genome from the Col-0. The SpliSER pipeline was slightly modified for SpliSE-QTL analysis. SpliSE-QTL pipeline assesses whether there are at least 3 triplicate values for SSE for any given genotype/site, and then uses the BAMs that pass this filter to produce the SSE for a given genomic interval (e.g., genes or genomic position or chromosome) across all the accessions.
As a proof-of-principle pilot-study, here we carried out SpliSE-QTL analysis for all splice sites across 50 genes that are known to undergo alternative splicing and nonsensemediated mRNA decay 29, 30 . SpliSE-QTL analysis detected close to 2000 splice sites across these genes. As expected, majority of the splice sites displayed minimal variation in SSE among accessions. However, there were sites with higher variability (Fig. 3a) . To assess the genetic component of this variation, we calculated heritability of the SSEs. The heritability varied substantially ( Fig. 3b ), which indicated that there are splice sites with genetically controlled variability in SSEs. We focused on splice sites that were: a) in the upper quartile for heritability and variance and b) with minimum 100 accessions.
We identified significant, reliable associations for 46 sites that are spread over 19 of the 50 genes (~38%) analysed in this pilot-study (Supplementary Table 1 ). To assess whether the GWAS signals are specific to splicing or simply reflected expression differences, we carried out eQTL analysis with the same set of accessions. We failed to detect overlapping GWAS signals for expression in most cases except for (FLM (At1g770880) & AT4G357885), potentially reflecting an association with NMD (Supplementary Table 2 ). To assess whether the SSEs are specific to splice-sites we compared the SSEs and GWASs with all SSEs in a single locus (FLM). SSEs differed between splice-sites within a gene, and not all sites gave a GWAS signal (Supplementary Table 3 ). Finally, similar associations were detected with competing sites (Supplementary Table 1 ). Taken together these findings suggest that the detected associations are specific to splice site and are associated with splicing differences rather than changes in gene expression.
To assess whether the associations hold up experimentally, we first analysed splicing of two sites at AT3G62190 that provided strong GWAS signals ( Fig. 4a & 4b ). SSE of two splice acceptor sites (canonical 23022226 & alternative 23022036) mapped to the same SNP (23022299). Common allele (G) at this SNP was associated with reduced strength of the canonical site and alternative allele (T) substantially increased the efficiency at the canonical site effectively competing out the alternative site ( Fig 4b) . Thus, accessions that differed at the associated SNP displayed distinct splicing patterns ( Fig. 4c ). We reasoned that if the observed associations are real, we should be able to predict the splicing patterns based on the genotype of the associated SNP. We tested this prediction using accessions that were not part of the GWAS panel. Consistent with our hypothesis, splicing patterns conformed with predictions ( Fig. 4c ). We carried out similar analysis with other loci and found them to conform predictions ( Supplementary Fig S1-S3 ), which provided experimental support for detected associations.
Having confirmed the associations, we considered whether SpliSE-QTL has the ability to pick up causal mutations. To assess this, we analysed whether any of the detected associations actually mapped to the splice-site itself in this dataset. Variation in SSE for two sites (AT2G18300_7953316/17, and AT5G65050_25985653/54) mapped to the splice sites themselves (Fig. 5a ). In addition, there were three more sites (AT5G46110_18699429/30, AT5G65050_25986012/13, AT5G65050/60_25989670/71), where the associated SNPs were within ±2bp of the splice site ( Fig. 5a ). While this is consistent with the idea that mutations at the splice site or in its vicinity would weaken the strength of a splice site, it also argues for the potential of SpliSE-QTL analysis to identify causal mutations underlying variation in splicing.
Next, we analysed the pattern of detected associations. We noticed that most of the GWAS signals (44 out of 49) were on the same chromosome as that of the splice site (Supplementary Table 1 ). To assess the pattern, we compiled the distances of the associated SNPs (Top 25 SNPs for each phenotype) from the splice site ( Supplementary Table 1, Fig. 5b ).
Distances clustered within 2Kb of the splice site ( Fig. 5b) . Most of the top-associated SNPs (32 out of 44) fell within 2Kb of the splice site (Fig 5c) , suggestive of a strong cis-effect. In fact, for 26 out 44 associations, we detected an associated SNP within 100 bp from the splice site (Supplementary Table 1 ). We also noted several instances of common associated SNPs for multiple splice-sites, which suggested the influence of one splice-site over the other through competition. These findings indicate that in this dataset, cis rather than trans-sequence variation and competition between splice-sites are among the primary drivers of variation in splicing.
A recent study utilized the same RNA-Seq data from the 1001 genome project and carried out isoform-based splicing QTL analysis 35 using sQTLseekeR 36 based UlfasQTL 37 analysis and concluded that majority of splicing variation in Arabidopsis is due to trans QTL [35] [36] [37] . This finding is in contrast to our current studies as well as earlier genetic studies 38 that argued for cis-regulatory variation as primary determinants of splicing. Therefore, we compared the GWAS results obtained in this study with ours for the common genes ( Supplementary Table 4 ).
We observed that the isoform-based approach failed to detect even a single SNP that we report for the same set of genes ( Supplementary Table 4 ). In addition, there was substantial noise in Khokhar et al's GWAS study such that associations were found with SNPs scattered around the entire genome, while we detected specific signals (Supplementary Table 4 , Supplementary Fig.   S4 ). Thus, in addition to reducing noise, SpliSE-QTL analysis also provided specific associations with splice-sites.
Having confirmed the utility of SpliSER, we also implemented a method that would allow detection of differentially spliced sites across the genome between samples. To assess the efficacy of this approach, we applied SpliSER on a previously published RNA-Seq data on quintuple mutants of the sc35-scl in Arabidopsis thaliana 25 . In this comparison, Yan et al, utilised ASD to detect 213 differentially spliced events representing 199 genes (p-value<0.05) of which 34 were detected after FDR based analysis (FDR<0.05) 25 . Applying SpliSER on the same data, we detected a total of 13094 splice-sites, representing 6457 genes to be differentially spliced (p-value<0.5), including 8 genes that were experimentally analysed by Yan et al (Supplementary Figure S5) . Applying Benjamini-Hochberg correction, we detected 4431 sites representing 2688 genes. Of these 1380 sites representing 1012 genes displayed more than 20% change in splicing efficiency. Even this stringent list contained 28 of the 34 genes identified through FDR analysis by Yan et al (Supplementary Figure S5) . Thus, diffSpliSE-analysis detected additional genes and provided splice-site based details of differential splicing.
To the best of our knowledge Splice-QTL is the only approach that allows detecting genetic variation that is associated with changes in splicing of a specific splice site. Our findings indicate that SpliSER provide reproducible quantification of SSE and SpliSE-QTL analysis has the potential to detect genomic determinants of variation in splicing. While our analysis is primarily based on short read RNA seq data, in theory the same principles could be applied with long-read data with minor changes. Our findings suggest that cis-regulatory changes and competition between splice-sites based on the splice-site strength could be among the key determinants of variation in splicing. While more work is needed to explain the mechanisms for each of these associations, we have demonstrated that these associated SNPs can be used as markers for tagging-splicing patterns. Splice-tagging SNPs would be of great use as markers having wide-ranging implications from agriculture to human disease. Future GWAS studies across genomes would unravel both the complexity and regulators of variation in splicing in an unprecedented fine scale.
Online Methods

Plant material/DNA/RNA Analyses
Seeds of the 1001 genome project accessions were obtained from European Arabidopsis Stock
Centre. DNA and RNA extractions were done as described previously 39 . For gene expression studies DNAse I (Roche)-treated 1ug of total RNA was used for cDNA synthesis using the First strand cDNA synthesis kit (Roche) and the resulting cDNA was diluted and used for RT-PCR experiments. Primers used in RT-PCR analysis are given in Supplementary Table 5 .
Splice-site Strength Estimation
SpliSER requires a BAM file of mapped RNA-seq reads and BED file that contains a list of splice junctions detected in the alignment (such as those produced during mapping by TopHat2 or HISAT2, or directly from a BAM file using Regtools 40 ). First, SpliSER uses the junctions BED file of each RNA-seq sample to define a list of splice sites observed in all samples; the read count of each junction is concurrently added to the α-read count for each of the two sites forming the junction. The list of "partners" (sites with which a given site has been observed to form a junction) is also recorded for each splice site. Second, SpliSER uses Samtools 41 view command to retrieve reads whose mapping covers each nucleotide either side of the splice-site, the CIGAR string of these reads are then traversed to identify reads which map perfectly on either side of the splice site; these are counted as β1-reads for each site. Third, SpliSER traverses the list of partners of each splice site -any α-read belonging to the regular partner and rare partners, but not used in a junction with the splice site under consideration, is counted as a β2-SIMPLE and β2-CRYPTIC -reads respectively. During the calculation of SSE a unit interval weight is applied to the β2-CRYPTIC-read count coming from each partner site, representing the relative occurrence of that splicing partnership (e.g., If Site A is observed to partner with Site B 9 times, and Site C (whose regular partner is not Site A) once-the β2-CRYPTIC reads from Site C will be assigned the weight 0.1. Thus Splice-site Strength Estimate is defined as where β2 P is the β2 read counts coming from partner P, and m the number of partners. In each sample, for each splice site; SpliSER filters those with too few reads (sum of α, β1, and β2: Default 10). These parameters could be adjusted to increase the sample size and we found that decreasing the sum count to as low as 3 still provided similar signals in SpliSE-QTL analysis.
URLs: SpliSER software, and scripts for statistical testing:
https://github.com/CraigIDent/SpliSER
SpliSE-QTL Analysis
For the SpliSE-QTL analysis, 6854 RNA-seq samples were downloaded from SRA, representing 728 accessions (PRJNA319904). Each sample was aligned to the TAIR10 reference genome using Tophat (v2.1.1; paramters --minIntronLength 20, --maxIntronLength 6000, -p 6) 42 . The resulting BAM files were indexed and sorted using Samtools sort v1.7 41 . The sorted BAM files and BED files for each sample were passed to SpliSER with a minimum of 10 evidencing reads required for a site to be called, and using a table adapted from the TAIR10_genes.gff3 annotation file to identify gene boundaries. The Splice-site Strength Estimate of each site in each of the 50 NMD target genes was quantified. The SSE phenotypes were further filtered using custom python scripts; an accession was only considered for further analysis for a given site if it had three or more individual RNA-seq samples underlying its average splicing efficiency value. A site was only considered for futher analysis if it contained 50 or more such accessions. We calculated the broad-sense heritability (H) and variance (v) of each splice site using a custom R script. GWAS experiments were performed using the easyGWAS 43 and/or GWAPP 44 web portal using the EMMAX/AMM algorithm with a minimum minor allele frequency of 5%, with no transformation of phenotypes.
To assess the relationship between heritability/variance and the ability to detect GWAS signals, we initially carried out GWAS with all 1500 phenotypes. Our findings suggested that most of the signals were detected among splice-sites with a higher levels of heritable phenotypic variation. When variance is low, it resulted in spurious signals throughout the genome. Therefore, each of the Mannhattan plots were individually inspected, before deciding on whether a GWAS signal that shows statistical significance is trustable. In subsequent iterations, only sites that were in the upper quartile of heritability and variance were taken for analysis. In total more than 1500 phenotypes were analysed through GWAS that ultimately resulted in 49 associations for 19 of the 50 analysed genes (Fig.4, Fig. 5, Supplementary Figures S6-S11 , Supplementary Table 1 ). All of these 49 were tested both through EMMAX algorithm or through AMM algorithm and both methods provided consistent signals. In instances where multiple SNPs that were in LD were giving same p-value of highest association, the closest SNP to the splice-site is presented in the Table. eQTL Analysis eQTL analysis was carried out using published expression levels for the RNA-Seq data using the same panel of accessions that contributed to the splicing-QTL for each of the phenotypes, using the same GWAS options described above. The data were then summarised at the gene level and if any one of the panel of accessions gave a eQTL signal, it was considered to be a positive overlapping QTL. This analysis resulted in two genes (FLM and At4g35875) having overlapping eQTL and SpliSE-QTL signals.
DiffSpliSE analysis
The six RNA-seq samples described in Yan et al 25 were aligned to the TAIR10 reference genome using TopHat2 v2.0.10 (parameters -i 20 -I 6000 -g 10 -r 0 --mate-std-dev 50 --coverage-search, and indexed using Samtools v1.2. Each resulting BAM and junction BED file, were processed with SPliSER (command: process, parameters -m 6000) using an annotation file derived from the TAIR10 genes.gff3 file. The resulting SpliSER.bed files were then combined (command: combineDeep; parameters -1 Chr1) and output (command: output; parameters -t diffSPliSE, -r 10). Differentially spliced sites (DiffSpliSE) were detected with a custom R script. Briefly, we remove all sites containing an NA in any sample generated by insufficient read coverage; then filter all sites whose mean SSE (average of all samples) is <0.05 or >0.95, blind to experimental grouping. We utilized the EdgeR package 45 
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